January 17, 2017
Biogen settles to pay Danish Forward $1.25 bilion
Danish biopharmaceutical company, Forward Pharma, has entered a deal with Biogen and certain other parties, regarding a Settlement and License Agreement.
Pharmaceuticals, Biotechnology and Life Sciences
Danish biopharmaceutical company, Forward Pharma, has entered a deal with Biogen and certain other parties, regarding a Settlement and License Agreement.